Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2024

Month: April

Request Number: A-2023-001205

Request Summary: Adverse Drug Reactions (ADRs) for Ondansetron. Report numbers: E2B_06666868, E2B_06659902, E2B_06697588, E2B_06702227, E2B_06662559,E2B_06707974. ADR for Dexilant. Report number: 001069005. ADR for Entyvio. Report number: E2B_06698466. ADR for Vedolizumab. Report number: 001059855. ADR for Ixazomib. Report number: E2B_06651889.

Disposition: Disclosed in part

Number of pages: 1174

Date modified: